S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
NYSE:INFY

Infosys - INFY Price Target & Analyst Ratings

$17.02
+0.22 (+1.31%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$16.83
$17.04
50-Day Range
$16.60
$19.51
52-Week Range
$16.39
$25.20
Volume
11.98 million shs
Average Volume
8.21 million shs
Market Capitalization
$71.25 billion
P/E Ratio
23.97
Dividend Yield
2.00%
Price Target
$20.29

Infosys Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 11 Analyst Ratings

Consensus Analyst Price Target

$20.29
19.19% Upside
High Prediction$23.00
Average Prediction$20.29
Low Prediction$18.00
TypeCurrent
3/28/22 to 3/28/23
1 Month Ago
2/26/22 to 2/26/23
3 Months Ago
12/28/21 to 12/28/22
1 Year Ago
3/28/21 to 3/28/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$20.29$20.71$21.06$25.76
Predicted Upside19.19% Upside12.62% Upside11.30% Upside15.00% Upside
Get Infosys Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for INFY and its competitors with MarketBeat's FREE daily newsletter.

INFY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

INFY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Infosys Stock vs. The Competition

TypeInfosysComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.27
2.55
2.47
Consensus RatingHoldBuyHold
Predicted Upside19.19% Upside212.00% Upside22.47% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/13/2023Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$25.00 ➝ $22.00+27.09%
1/13/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$20.00 ➝ $21.00+14.13%
10/14/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform$19.00 ➝ $18.00-0.28%
10/14/2022Investec
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/16/2022Susquehanna Bancshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral$29.00 ➝ $20.00+12.42%
9/13/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Sell
8/22/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral
5/31/2022HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
4/13/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$23.00+8.54%
4/11/2022Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
2/23/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kunal Tayal
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$24.50+7.83%
4/14/2021Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderperform$17.00 ➝ $18.00-2.23%
3/29/2021Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$20.33 ➝ $21.80+16.45%
10/14/2020William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Nolan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
7/16/2020Nomura Instinet
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
4/21/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$11.00 ➝ $9.50+14.73%
4/14/2020Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Edward Caso
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight$11.50 ➝ $9.00+4.53%
(Data available from 3/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












INFY Price Target - Frequently Asked Questions

What is Infosys's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Infosys stock is Hold based on the current 1 sell rating, 6 hold ratings and 4 buy ratings for INFY. The average twelve-month price prediction for Infosys is $20.29 with a high price target of $23.00 and a low price target of $18.00. Learn more on INFY's analyst rating history.

Do Wall Street analysts like Infosys more than its competitors?

Analysts like Infosys less than other Computer and Technology companies. The consensus rating for Infosys is Hold while the average consensus rating for computer and technology companies is Buy. Learn more on how INFY compares to other companies.

Does Infosys's stock price have much upside?

According to analysts, Infosys's stock has a predicted upside of 11.76% based on their 12-month price targets.

What analysts cover Infosys?

Infosys has been rated by BMO Capital Markets, and Wedbush in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:INFY) was last updated on 3/28/2023 by MarketBeat.com Staff